TNFSF13B and systemic lupus erythematosus: Belimumab, a human monoclonal antibody that inhibits B-cell-activating factor (BAFF or BLyS), was approved by the FDA in 2011 for SLE treatment due to its demonstrated efficacy in clinical trials [91].